Advertisement

Reactions Weekly

, Volume 1778, Issue 1, pp 118–118 | Cite as

Carboplatin/paclitaxel

Peripheral neuropathy: case report
Case report
  • 33 Downloads

Reference

  1. Fujiwara M, et al. Efficacy and Safety of Carboplatin Plus Paclitaxel as the First-, Second-, and Third-line Chemotherapy in Men With Castration-resistant Prostate Cancer. Clinical Genitourinary Cancer 17: e923-e929, No. 5, Oct 2019. Available from: URL: http://doi.org/10.1016/j.clgc.2019.04.017 - JapanCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations